Undoctored vault view

Sukin has evolved considerably over the past 10 years since its natural skincare products launched.

The Pharmacy Guild of New Zealand (the Guild) congratulates Feilding Health Pharmacy for winning the Community Pharmacy of the Year award at the 2018 Pharmacy Awards held on Saturday night (28 July). 

PHARMAC is pleased to provide another treatment option for patients with severe osteoporosis following the funding of denosumab, brand name Prolia, from 1 July 2018.

The Ministry of Health’s online FluTracking initiative is boosting understanding of influenza.

The Pharmacy Guild of New Zealand (the Guild) is gearing up to hold our annual Pharmacy Business Network (PBN) in just over a month’s time, on Saturday 28 July 2018, at the Pullman Hotel in Auckland. 

Bayer has announced that from 1 June, EYLEA® (aflibercept) will be accessible as the second-line treatment option for Wet Age Related Macular Degeneration (wet-AMD) and Diabetic Macular Oedema (DMO) and will be made available in both hospitals and the community. PHARMAC funding was granted earlier this month and is expected to benefit around 900 people in its first year.¹